Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KBD102430 in Advanced Solid Tumors (Phase I/II)
CTR20263128Phase 2Active
- Sponsor
- Combi-Blocks
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KBD102430 in Non-hematologic malignancy, ovarian cancer, breast cancer, prostate cancer (PCa), sponsored by Combi-Blocks. Started Aug 2026; status: active.
02
Drugs
KBD102430
03
Conditions
Non-hematologic malignancyovarian cancerbreast cancerprostate cancer (PCa)
Beyond the preview
Go deeper on CTR20263128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263128.